NICE OK for life-extending Vizimpro in lung cancer
It’s a change from the committee’s initial decision which found the tyrosine kinase inhibitor to not be a cost-effective use of NHS resources.
Read More
Tag: Vizimpro
Migraine treatment Ajovy among CHMP’s six endorsed medicines
Six medicines have taken a giant leap toward winning approval in Europe having won the backing of the European Medicines Agency’s (EMA) human medicines committee (CHMP).
Read More
US green light for Pfizer’s lung cancer drug
Pfizer’s pan-human epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor dacomitinib has been approved in the US as a treatment for some forms of lung cancer.
Read More
- King’s Doctoral Training Centre to investigate MS symptom management
- Agenda announced for FlyPharma Vienna 2024
- Therapy reprogrammes immune cells to shrink prostate and bladder cancers
- Researchers combine herpes virus with cancer vaccine to treat brain cancer in children
- UK MRC and AstraZeneca partner for translational clinical research
